{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:10:58Z","timestamp":1780431058004,"version":"3.54.1"},"posted":{"date-parts":[[2026,3,16]]},"group-title":"In Review","reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,5]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  The mechanisms by which apolipoprotein E (\n                  <italic>APOE<\/italic>\n                  ) drives copathologies in established Alzheimer\u2019s disease (AD) dementia via amyloid-dependent versus age-driven pathways remain unresolved. Analyzing data from 11,897 autopsied individuals from the National Alzheimer's Coordinating Center, with copathology analyses restricted to amyloid-positive AD dementia, we show that\n                  <italic>APOE<\/italic>\n                  effects followed two distinct trajectories. Cerebral amyloid angiopathy exhibited a striking \u03b54 dose-response (OR = 5.76, 95% CI: 4.20\u20137.96, p &lt; 0.001; for \u03b54\/\u03b54 compared to \u03b53\/\u03b53), whereas arteriolosclerosis and atherosclerosis risk increased with age, independent of\n                  <italic>APOE<\/italic>\n                  haplotype. Lewy body pathology showed modest\n                  <italic>APOE<\/italic>\n                  associations restricted to limbic\/amygdalar-predominant forms and was related to dementia duration, suggesting AD-mediated secondary synucleinopathy. TDP-43 pathology was associated with chronological age, demonstrating regional progression with minimal\n                  <italic>APOE<\/italic>\n                  dependence. These findings suggests that in amyloid-positive AD dementia,\n                  <italic>APOE<\/italic>\n                  \u03b54 selectively amplifies amyloid-related pathology, particularly cerebral amyloid angiopathy, while other copathologies accumulate through age-driven,\n                  <italic>APOE<\/italic>\n                  haplotype-independent processes.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9044264\/v1","type":"posted-content","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:42:19Z","timestamp":1773643339000},"source":"Crossref","is-referenced-by-count":0,"title":["Amyloid-linked versus age-driven copathologies in Alzheimer\u2019s dementia: differential associations with APOE \u03b54"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3039-9115","authenticated-orcid":false,"given":"\u00cd\u00f1igo","family":"Rodr\u00edguez-Baz","sequence":"first","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-6559","authenticated-orcid":false,"given":"Lidia","family":"Vaqu\u00e9-Alc\u00e1zar","sequence":"additional","affiliation":[{"name":"University of Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-7971","authenticated-orcid":false,"given":"Luc\u00eda","family":"Maure-Blesa","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Pertierra","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-1215","authenticated-orcid":false,"given":"Javier Arranz","family":"Martinez","sequence":"additional","affiliation":[{"name":"Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4068-8578","authenticated-orcid":false,"given":"Laura","family":"Molina-Porcel","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-7453","authenticated-orcid":false,"given":"Iban","family":"Aldecoa","sequence":"additional","affiliation":[{"name":"cHospital Cl\u00ednic Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1557-7350","authenticated-orcid":false,"given":"Naomi","family":"Ferreira","sequence":"additional","affiliation":[{"name":"University of Sao Paulo Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Paradela","sequence":"additional","affiliation":[{"name":"University of Sao Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9748-8465","authenticated-orcid":false,"given":"Laura","family":"Videla","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Barroeta","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Carmona-Iragui","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Bel\u00e9n","family":"S\u00e1nchez-Saudin\u00f3s","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Selma-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-8748","authenticated-orcid":false,"given":"Oriol","family":"Dols-Icardo","sequence":"additional","affiliation":[{"name":"Institut de recerca de l'hospital de Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Rozalem","family":"Aranha","sequence":"additional","affiliation":[{"name":"Institut de Recerca Hospital de la Santa Creu i Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f2nia Sirisi","family":"Dolcet","sequence":"additional","affiliation":[{"name":"Institut de Recerca Sant Pau (IR SANT PAU), Hospital de la Santa Creu i Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Abdelnour","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Ill\u00e1n-Gala","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau- Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-3245","authenticated-orcid":false,"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[{"name":"Hospital de Sant Pau - IIB Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-5478","authenticated-orcid":false,"given":"Alberto","family":"Lleo","sequence":"additional","affiliation":[{"name":"Institut de Recerca Sant Pau (IR SANT PAU), Hospital de la Santa Creu i Sant Pau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5942-4778","authenticated-orcid":false,"given":"Claudia","family":"Suemoto","sequence":"additional","affiliation":[{"name":"University of Sao Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-638X","authenticated-orcid":false,"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau- Universitat Aut\u00f2noma de Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","first-page":"83","article-title":"Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development","volume":"3","author":"Rabinovici GD","year":"2017","unstructured":"Rabinovici GD et al (2017) Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development. Alzheimers Dement 3:83\u201391","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle PA","year":"2019","unstructured":"Boyle PA et al (2019) Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann Neurol 85:114\u2013124","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jnen\/nlae122","article-title":"Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes","volume":"84","author":"Sepulveda-Falla D","year":"2025","unstructured":"Sepulveda-Falla D et al (2025) Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes. J Neuropathol Exp Neurol 84:104\u2013113","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-215675","article-title":"Patterns of Mixed Pathologies in Down Syndrome","volume":"87","author":"Ichimata S","year":"2022","unstructured":"Ichimata S et al (2022) Patterns of Mixed Pathologies in Down Syndrome. J Alzheimers Dis JAD 87:595\u2013607","journal-title":"J Alzheimers Dis JAD"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman EM","year":"2020","unstructured":"Reiman EM et al (2020) Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun 11:667","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li Z","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G (2020) APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener 15:63","journal-title":"Mol Neurodegener"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson DW","year":"2018","unstructured":"Dickson DW et al (2018) APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182\u2013e1195","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology","volume":"143","author":"Jin Y","year":"2022","unstructured":"Jin Y et al (2022) APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol (Berl) 143:641\u2013662","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","article-title":"Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study","volume":"17","author":"Yang H-S","year":"2018","unstructured":"Yang H-S et al (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol 17:773\u2013781","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","article-title":"APOE-\u03b52 and APOE-\u03b54 Correlate with Increased Amyloid Accumulation in Cerebral Vasculature","volume":"72","author":"Nelson PT","year":"2013","unstructured":"Nelson PT et al (2013) APOE-\u03b52 and APOE-\u03b54 Correlate with Increased Amyloid Accumulation in Cerebral Vasculature. J Neuropathol Exp Neurol 72:708\u2013715","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea J","year":"2024","unstructured":"Fortea J et al (2024) APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med 30:1284\u20131291","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41593-025-02000-6","article-title":"Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-\u03b2 status, APOE genotype and sex","volume":"28","author":"Ossenkoppele R","year":"2025","unstructured":"Ossenkoppele R et al (2025) Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-\u03b2 status, APOE genotype and sex. Nat Neurosci 28:1610\u20131621","journal-title":"Nat Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/brain\/awaf016","article-title":"APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-\u03b2","volume":"148","author":"Cicognola C","year":"2025","unstructured":"Cicognola C et al (2025) APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-\u03b2. Brain J Neurol 148:2373\u20132383","journal-title":"Brain J Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nly049","article-title":"The Revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology Form-Available Data and New Analyses","volume":"77","author":"Besser LM","year":"2018","unstructured":"Besser LM et al (2018) The Revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol 77:717\u2013726","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal DR","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak H","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H (2006) Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112:389\u2013404","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra SS","year":"1991","unstructured":"Mirra SS et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","volume":"11","author":"Clark CM","year":"2012","unstructured":"Clark CM et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol 11:669\u2013678","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","article-title":"Multisite study of the relationships between antemortem [11 C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology","volume":"15","author":"Joie R","year":"2019","unstructured":"La Joie R et al (2019) Multisite study of the relationships between antemortem [11 C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology. Alzheimers Dement 15:205\u2013216","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"13859","author":"Jack CR","year":"2024","unstructured":"Jack CR et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement alz 13859. 10.1002\/alz.13859","journal-title":"Alzheimers Dement alz"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith IG","year":"2005","unstructured":"McKeith IG et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme","volume":"131","author":"Josephs KA","year":"2016","unstructured":"Josephs KA et al (2016) Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol (Berl) 131:571\u2013585","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","article-title":"LATE-NC staging in routine neuropathologic diagnosis: an update","volume":"145","author":"Nelson PT","year":"2023","unstructured":"Nelson PT et al (2023) LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol (Berl) 145:159\u2013173","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e70927","DOI":"10.1002\/alz.70927","article-title":"Apolipoprotein E and Alzheimer\u2019s disease pathology in a diverse autopsy study","volume":"21","author":"Suemoto CK","year":"2025","unstructured":"Suemoto CK et al (2025) Apolipoprotein E and Alzheimer\u2019s disease pathology in a diverse autopsy study. Alzheimers Dement 21:e70927","journal-title":"Alzheimers Dement"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14039","article-title":"In vivo detection of Alzheimer\u2019s and Lewy body disease concurrence: Clinical implications and future perspectives","volume":"14039","author":"Baiardi S","year":"2024","unstructured":"Baiardi S, Hansson O, Levin J, Parchi P (2024) In vivo detection of Alzheimer\u2019s and Lewy body disease concurrence: Clinical implications and future perspectives. Alzheimers Dement alz 14039. 10.1002\/alz.14039","journal-title":"Alzheimers Dement alz"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1002\/alz.13818","article-title":"\u03b1-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer\u2019s disease late in the disease course and dependent on Lewy pathology burden","volume":"20","author":"Levin J","year":"2024","unstructured":"Levin J et al (2024) \u03b1-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer\u2019s disease late in the disease course and dependent on Lewy pathology burden. Alzheimers Dement 20:4351\u20134365","journal-title":"Alzheimers Dement"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e70342","DOI":"10.1002\/alz.70342","article-title":"Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer\u2019s disease","volume":"21","author":"Bernhardt AM","year":"2025","unstructured":"Bernhardt AM et al (2025) Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer\u2019s disease. Alzheimers Dement 21:e70342","journal-title":"Alzheimers Dement"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2016.4926","article-title":"Duration and Pathologic Correlates of Lewy Body Disease","volume":"74","author":"Graff-Radford J","year":"2017","unstructured":"Graff-Radford J et al (2017) Duration and Pathologic Correlates of Lewy Body Disease. JAMA Neurol 74:310\u2013315","journal-title":"JAMA Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","article-title":"Association of Apolipoprotein E \u03b54 With Transactive Response DNA-Binding Protein 43","volume":"75","author":"Wennberg AM","year":"2018","unstructured":"Wennberg AM et al (2018) Association of Apolipoprotein E \u03b54 With Transactive Response DNA-Binding Protein 43. JAMA Neurol 75:1347\u20131354","journal-title":"JAMA Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson PT","year":"2019","unstructured":"Nelson PT et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527","journal-title":"Brain"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnen\/nlae032","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis","volume":"83","author":"Nelson PT","year":"2024","unstructured":"Nelson PT et al (2024) Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis. J Neuropathol Exp Neurol 83:396\u2013415","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1038\/s41467-025-59216-0","article-title":"Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing","volume":"16","author":"Pottier C","year":"2025","unstructured":"Pottier C et al (2025) Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing. Nat Commun 16:3914","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.tins.2025.06.005","article-title":"Genetic architecture of FTLD-TDP pathological subtypes","volume":"48","author":"Dols-Icardo O","year":"2025","unstructured":"Dols-Icardo O, Reus LM, Ramirez A (2025) Genetic architecture of FTLD-TDP pathological subtypes. Trends Neurosci 48:553\u2013554","journal-title":"Trends Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlx099","article-title":"The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases","volume":"77","author":"Nelson PT","year":"2018","unstructured":"Nelson PT et al (2018) The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases. J Neuropathol Exp Neurol 77:2\u201320","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00401-025-02952-w","article-title":"Alpha-synuclein deposition patterns in Alzheimer\u2019s disease: association with cortical amyloid beta and variable tau load","volume":"150","author":"Neubauer A","year":"2025","unstructured":"Neubauer A et al (2025) Alpha-synuclein deposition patterns in Alzheimer\u2019s disease: association with cortical amyloid beta and variable tau load. Acta Neuropathol (Berl) 150:46","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"fcaa090","DOI":"10.1093\/braincomms\/fcaa090","article-title":"Differential cross-seeding properties of tau and \u03b1-synuclein in mouse models of tauopathy and synucleinopathy","volume":"2","author":"Williams T","year":"2020","unstructured":"Williams T, Sorrentino Z, Weinrich M, Giasson BI, Chakrabarty P (2020) Differential cross-seeding properties of tau and \u03b1-synuclein in mouse models of tauopathy and synucleinopathy. Brain Commun 2:fcaa090","journal-title":"Brain Commun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"fcae442","DOI":"10.1093\/braincomms\/fcae442","article-title":"Amygdala-predominant \u03b1-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer\u2019s disease","volume":"6","author":"Gawor K","year":"2024","unstructured":"Gawor K et al (2024) Amygdala-predominant \u03b1-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer\u2019s disease. Brain Commun 6:fcae442","journal-title":"Brain Commun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2014.681","article-title":"Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically-verified Alzheimer\u2019s disease","volume":"71","author":"Ringman JM","year":"2014","unstructured":"Ringman JM et al (2014) Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically-verified Alzheimer\u2019s disease. JAMA Neurol 71:878\u2013883","journal-title":"JAMA Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.27253","article-title":"Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort","volume":"98","author":"Bruce SS","year":"2025","unstructured":"Bruce SS et al (2025) Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort. Ann Neurol 98:249\u2013257","journal-title":"Ann Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jalz.2018.08.007","article-title":"APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults","volume":"15","author":"Lamar M","year":"2019","unstructured":"Lamar M et al (2019) APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement 15:258\u2013266","journal-title":"Alzheimers Dement"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"107479","DOI":"10.1016\/j.carpath.2022.107479","article-title":"Apolipoprotein E genotypes were not associated with intracranial atherosclerosis: a population-based autopsy study","volume":"62","author":"Paradela RS","year":"2023","unstructured":"Paradela RS et al (2023) Apolipoprotein E genotypes were not associated with intracranial atherosclerosis: a population-based autopsy study. Cardiovasc Pathol 62:107479","journal-title":"Cardiovasc Pathol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9044264\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9044264\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:38:01Z","timestamp":1780429081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9044264\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":41,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9044264\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,3,16]]},"subtype":"preprint"}}